Critical care (London, England), 2021-09, Vol.25 (1), p.348-348, Article 348
2021
Details
- Autor(en) / Beteiligte
- Titel
- Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19
- Ist Teil von
- Critical care (London, England), 2021-09, Vol.25 (1), p.348-348, Article 348
- Ort / Verlag
- England: BioMed Central Ltd
- Erscheinungsjahr
- 2021
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- No statistical sample size calculation was performed a priori, and sample size was equal to the number of patients treated during the study period. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa J-M, Bretagne S. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1364-8535eISSN: 1466-609XDOI: 10.1186/s13054-021-03767-3Titel-ID: cdi_doaj_primary_oai_doaj_org_article_c78384d7e6854c67a24254fecf9992c0
- Format
- –
- Schlagworte
- Acute respiratory distress syndrome, Aged, Comorbidity, Complications and side effects, Coronaviruses, COVID-19, COVID-19 - epidemiology, COVID-19 - virology, Diagnosis, Distribution, Female, Humans, Influenza, Life Sciences, Male, Middle Aged, Mortality, Opportunistic Infections - epidemiology, Opportunistic Infections - microbiology, Patients, Pneumocystis carinii, Pneumocystis carinii pneumonia, Pneumonia, Pneumonia, Pneumocystis - epidemiology, Pneumonia, Pneumocystis - microbiology, Pneumonia, Pneumocystis - virology, Prevalence, Research Letter, Respiratory distress syndrome, Respiratory Distress Syndrome - epidemiology, Respiratory Distress Syndrome - microbiology, Respiratory Distress Syndrome - virology, Retrospective Studies, Risk Factors, Sample size, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2